# Kaneka Endovascular Embolization and Protection

Study · id `cardio:ct-nct05563051` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05563051](<https://clinicaltrials.gov/study/NCT05563051>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05563051

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 164 participants.

## Technical summary

Registry record NCT05563051. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-13 (actual); primary completion 2025-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 164 participants (planned count; ClinicalTrials.gov record NCT05563051, source copy `cardio:ctgov-nct05563051-2025-10-07`, retrieved 2026-11-18)
- Started: 2022-12-13 (actual) (ClinicalTrials.gov record NCT05563051, source copy `cardio:ctgov-nct05563051-2025-10-07`, retrieved 2026-11-18)
- Primary completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT05563051, source copy `cardio:ctgov-nct05563051-2025-10-07`, retrieved 2026-11-18)
- Completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT05563051, source copy `cardio:ctgov-nct05563051-2025-10-07`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05563051, source copy `cardio:ctgov-nct05563051-2025-10-07`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05563051-2025-10-07`, retrieved 2026-11-18)

## The registry's words

- Brief title: Kaneka Endovascular Embolization and Protection
- Acronym: KEEP
- Condition: Aneurysm Cerebral
- Intervention (Device): i-ED COIL
- Lead sponsor: Kaneka Medical America LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)

## Provenance

Content hash: 0c5f15da16293f61ac49b2eedfc5bc1706ab6f759c504be6b75e7c2849ece07d
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
